Our lab employs a multidisciplinary approach at the interface of chemistry and biology to investigate the structure-function relationships of novel immunomodulatory proteins in cancer, and develop new approaches for targeting difficult proteins that are involved in cancer progression. Our ultimate goal is to develop target-specific small molecule modulators that can be used either for therapeutic purposes or as agents to understand the biological function of the protein under study.